Stage IIIA Lung Cancer AJCC V8

AUG 11, 2026 · PHASE 3 TRIAL

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no reported results; the study is active but not yet recruiting and outcome data are not posted in this registry record.

AUG 11, 2026 · PHASE 3 TRIAL

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is active but not yet recruiting and outcome data are not available.

AUG 10, 2026 · PHASE 3 TRIAL

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the trial is actively recruiting and designed to compare durvalumab against observation in early-stage NSCLC after surgery, but outcome data are not yet available.